NK-cells antibodies

Introduction to NK-cells

Natural Killer (NK) cells are a vital component of the innate immune system, renowned for their ability to identify and eliminate infected or malignant cells without prior sensitization. Unlike other immune cells, NK cells operate swiftly, providing the first line of defense against a wide range of threats, including viruses and cancerous transformations. Their unique mechanism of action involves recognizing stressed cells through a balance of activating and inhibitory receptors, ensuring targeted and efficient responses. Recent advancements in immunotherapy have spotlighted NK cells as promising candidates for antibody-based treatments, leveraging their natural cytotoxic abilities to enhance therapeutic efficacy. Our cutting-edge research focuses on harnessing and optimizing NK-cell related antibodies to develop innovative therapies, aiming to revolutionize treatments for various diseases and improve patient outcomes.

Contents:

1. NK-cells Biomarkers
2. Important Mechanisms

NK-cells biomarkers

Protein Name	Gene Name	Function
CD56	NCAM1	Cell adhesion molecule important for NK cell identification and cytotoxicity.
NKG2D	KLRK1	Activating receptor that recognizes stress-induced ligands on target cells.
CD16	FCGR3A	Fc receptor involved in antibody-dependent cellular cytotoxicity (ADCC).
NKp30	NCR3	Natural cytotoxicity receptor involved in NK cell activation and tumor cell recognition.
NKp46	NCR1	Natural cytotoxicity receptor critical for NK cell-mediated killing of virus-infected cells.
NKG2A	KLRC1	Inhibitory receptor that recognizes HLA-E, regulating NK cell activity.
CD94	KLRC2	Partner of NKG2A, involved in inhibitory signaling upon binding HLA-E.
KIR2DL1	KIR2DL1	Inhibitory killer-cell immunoglobulin-like receptor recognizing HLA-C2 group alleles.
KIR3DL1	KIR3DL1	Inhibitory receptor targeting HLA-Bw4 alleles, regulating NK cell inhibition.
CD69	CD69	Activation marker indicating recent activation of NK cells.
CD25	IL2RA	Alpha chain of IL-2 receptor, involved in NK cell proliferation and activation.
Granzyme B	GZMB	Serine protease involved in inducing apoptosis in target cells.
Perforin	PRF1	Pore-forming protein facilitating entry of granzymes into target cells.
CD107a	LAMP1	Marker of degranulation indicating NK cell cytotoxic activity.
TIM-3	HAVCR2	Immune checkpoint receptor regulating NK cell exhaustion and function.
LAG-3	LAG3	Immune checkpoint molecule involved in NK cell regulation and inhibition.
CD57	B3GAT1	Marker of terminal differentiation and senescence in NK cells.
ICOS	ICOS	Costimulatory molecule enhancing NK cell proliferation and cytokine production.
PD-1	PDCD1	Immune checkpoint receptor modulating NK cell activity in tumor environments.
BTLA	BTLA	Inhibitory receptor regulating NK cell function and immune tolerance.
Siglec-7	SIGLEC7	Inhibitory receptor recognizing sialic acid-containing ligands, regulating NK cell activation.

Important Mechanisms

NK Cell Activation and Inhibition Pathways

Natural Killer (NK) cell activation and inhibition constitute a finely tuned balance that determines their responsiveness to target cells. NK cells possess a repertoire of activating and inhibitory receptors on their surface, enabling them to distinguish between healthy cells and those infected by pathogens or undergoing malignant transformation. Activating receptors, such as NKG2D and NKp30, recognize stress-induced ligands on target cells, triggering cytotoxic responses. Conversely, inhibitory receptors like KIRs (Killer-cell Immunoglobulin-like Receptors) and NKG2A bind to MHC class I molecules typically expressed on healthy cells, sending inhibitory signals that prevent unwarranted NK cell activation. This dual receptor system ensures that NK cells can effectively eliminate abnormal cells while sparing normal, healthy tissues. Understanding the molecular mechanisms governing these pathways is crucial for developing therapeutic strategies that can enhance NK cell activity against cancers and viral infections without compromising immune tolerance.

NK Cell Cytotoxic Mechanisms and Immune Surveillance

NK cells play a pivotal role in the immune surveillance system through their ability to induce apoptosis in target cells. This cytotoxic function is primarily mediated by the release of cytotoxic granules containing perforin and granzymes. Perforin forms pores in the membrane of target cells, allowing granzymes to enter and activate apoptotic pathways, leading to cell death. Additionally, NK cells can induce apoptosis via death receptor pathways, such as Fas-FasL interactions. Beyond direct killing, NK cells secrete cytokines like IFN-γ and TNF-α, which modulate the immune response and enhance the recruitment and activation of other immune cells. The efficiency and regulation of these cytotoxic mechanisms are vital for controlling tumor growth and eliminating virally infected cells. Research in this area focuses on harnessing and enhancing NK cell cytotoxicity for therapeutic interventions, including cancer immunotherapy and treatments for persistent viral infections.